Keywords: Diffusion tensor imaging; Neuroimaging; Hurler; Scheie; Enzyme replacement therapy; Lysosomal storage disease; Anisotropy; Brain;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy
Keywords: Enzyme replacement therapy; Scheie; Macula; Mucopolysaccharidosis type I; Iduronidase;
Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I
Keywords: Hurler; Scheie; Lysosomal storage disease; Enzyme replacement therapy; Alpha-l-iduronidase; Intrathecal;
Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
Keywords: Mucopolysaccharidosis type I; α-l-Iduronidase; Hurler; Scheie; Mutational analysis; Bioinformatic model
Residual α-l-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients
Keywords: 4MU; 4-methylumbelliferone; ERT; enzyme-replacement therapy; HSCT; hematopoietic stem cell transplantation; IDUA; α-l-iduronidase; MPS; mucopolysaccharidosis; MPS IH; Hurler syndrome; MPS IH/S; Hurler-Scheie syndrome; MPS IS; Scheie syndrome; Mucopolys
High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry
Keywords: Mucopolysaccharidosis I; Hurler; Hurler-Scheie; Scheie; Surgery; Mortality; Anesthetic complications
Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase
Keywords: Mucopolysaccharidosis; MPS; Hurler; Scheie; Laronidase;
A dose-optimization trial of laronidase (Aldurazyme®) in patients with mucopolysaccharidosis I
Keywords: Mucopolysaccharidosis (MPS) type I; Hurler; Hurler–Scheie; Scheie; Laronidase; Clinical trial; Dose-optimization; Glycosaminoglycans; Enzyme replacement therapy
Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluid
Keywords: Mucopolysaccharidosis I; Lysosomal storage disorder; Intrathecal; Enzyme replacement therapy; Central nervous system; Cerebrospinal fluid; Hurler; Scheie; Hurler-Scheie; Pachymeningitis;
A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years
Keywords: Cardiac function; Efficacy; Enzyme replacement therapy; Hurler–Scheie; Joint stiffness; Laronidase; Mucopolysaccharidosis I; Scheie
The MPS I registry: Design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I
Keywords: α-l-Iduronidase; Enzyme replacement therapy (ERT); Glycosaminoglycan (GAG); Hematopoietic stem cell transplantation (HSCT); Hurler; Hurler–Scheie; Laronidase; Lysosomal storage disorder; Mucopolysaccharidosis I (MPS I); Registry; Scheie
Mucopolysaccharidoses and the Eye
Keywords: Hunter; Hurler; Maroteaux-Lamy; Morquio; mucopolysaccharidosis; Natowicz; Sanfilippo; Scheie; Sly
Penetration, diffusion, and uptake of recombinant human α-l-iduronidase after intraventricular injection into the rat brain
Keywords: Lysosomal storage disease; Hurler; Scheie; α-l-Iduronidase; Mucopolysaccharidosis; Brain; Rat;